메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

BEIJING, Aug. 18, 2025 -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that its board of directors (the "Board") has received a preliminary non-binding proposal letter (the "Proposal Letter"), dated August 18, 2025, from Oceanpine Investment Fund II LP and Oceanpine Capital Inc. (collectively, "Oceanpine
- 황정호 기자
- 2025-08-18 20:00
KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS

Revenue reached approximately RMB950.4 million, with total commercial sales RMB309.8million, representing a significant increase in proportion Research and development expenses was approximately RMB611.5 million Loss for the period was RMB145.2 million; adjusted loss for the period[1] was RMB69.4 million Cash and cash equivalents[2] amounted to approximately RMB4527.8 million, reflecting ample cash reserves Note1: Calculated by deducting equity-settled share-based payment from loss for the year. Note2: Comprises cash and cash eq
- 김갑성 기자
- 2025-08-18 18:29
India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

NEW DELHI, Aug. 18, 2025 -- Manipal Hospitals, one of India's leading and globally recognized healthcare institutions, welcomes one of India's most renowned robotic oncosurgeons, Dr. Surender Kumar Dabas as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster. With this addition, the hospital across Delhi, Gurugram and Ghaziabad further reinforces its vision to be a destination for world-class cancer care, catering to patients across India as well as international geographies. Dr. Surender Dabas brings with him more than 22
- 김갑성 기자
- 2025-08-18 18:23
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies

YONGIN, South Korea, Aug. 18, 2025 -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced today that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Society (TRCS) to cooperate on workforce training for the production of plasma-derived medicinal products. This MOU formalizes and deepens a relationship that began in 2015, when GC Biopharma supported TRCS to establish a plasma fractionation facility in Thailand, and reflects the ongoing strategic collaboration between the two parties. Under the terms of the
- 김갑성 기자
- 2025-08-18 12:40
Next Generation Refractive Surgery to LASIK and SMILE Now Available for Clinical Review

Pioneer surgeon Dr Natasha Lim is among the first in Singapore to offer Smooth Incision Lenticular Keratomileusis (SILK) procedure in their clinics. SINGAPORE, Aug. 18, 2025 -- Dr. Natasha Lim, an internationally renowned surgeon in Ophthalmology, has introduced an alternative to established refractive surgery techniques for medical practitioners in Singapore to explore. Smooth Incision Lenticule Keratomileusis (SILK), a recent advancement in laser vision correction, offers a potentially improved approach to correcting myopia and astigmatism. SILK is a flapless refractive surgery that
- 김갑성 기자
- 2025-08-18 11:00
Herbalgy, Pain Management Expert, Harnesses the Wisdom of Traditional Chinese Medicine to Safeguard Hong Kong's Health, Proudly Appoints Moses Chan as Brand Ambassador

Download high-resolution images: https://cutt.ly/IrGBefFJ HONG KONG, Aug. 18, 2025 -- As Hong Kong's pain management expert, Herbalgy has been serving the community since its founding in 1999. For over 25 years, the brand has been dedicated to promoting healthy living and pain management, with a steadfast commitment to product innovation. By integrating the wisdom of Traditional Chinese Medicine (TCM) into modern life, Herbalgy has become a trusted name among Hong Kong people. Shared Values, Shared Mission Herbalgy has officially appointed Moses Chan — one
- 김갑성 기자
- 2025-08-18 10:00
New support group to provide social and community support for neurofibromatosis patients

[ 메디채널 김갑성 기자 ] Co-founded by individuals living with this rare genetic condition, the Neurofibromatosis Society Singapore seeks to close gaps in mental and emotional care SINGAPORE, Aug. 18, 2025 -- A new patient-led support group, the Neurofibromatosis Society (NFS) Singapore, has been recently registered with the Registry of Societies to provide emotional, psychosocial, and financial support for people affected by neurofibromatosis (NF) – a rare genetic condition that causes the development of tumours affecting nerves on the skin, brain, spinal cord and other parts of the body.&n
- 김갑성 기자
- 2025-08-18 09:00
Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity

- Combination of a low dose of ASC47 with ASC31, a novel peptide agonist targeting both GLP-1 receptor (GLP-1R) and GIP receptor (GIPR), resulted in a 44.8% reduction in body weight after 14 days of treatment in a diet-induced obese (DIO) mouse model. - Combination of a low dose of ASC47 with ASC31 demonstrated statistically significantly greater efficacy than a combination of a low dose of ASC47 with tirzepatide, 44.8% compared to 38.1%, respectively, in the DIO mouse model. HONG KONG, Aug. 18, 2025 -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces encouragi
- 김갑성 기자
- 2025-08-18 08:15
GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation

[ 메디채널 김갑성 기자 ] Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value Creation PISCATAWAY, N.J., Aug. 17, 2025 -- GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 2025, underscoring its ability to deliver profitable growth at scale through strategic globalization, differentiated technology, and relentless innovation. Fueled by robust demand across all business segments and expansion into key international markets, GenScript achie
- 김갑성 기자
- 2025-08-17 20:01
VARON's Lung Health Awareness Initiative Urges Proactive Steps for Allergy and Flu this Fall Season

NEW YORK, Aug. 15, 2025 -- With allergy and flu season approaching, VARON is calling on individuals to take preventive measures to protect their lungs. Through its "Every Breath Counts" initiative, the oxygen concentrator manufacturer is partnering with respiratory health experts to share practical lung care strategies and introduce tools — from at home oxygen concentrators to lightweight portable oxygen concentrators — to help people maintain optimal oxygen levels during seasonal flare-ups. As part of its Every Breath Counts initiative, VARON recently h
- 김갑성 기자
- 2025-08-15 23:08

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-08-30_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 08월 31일 01시 20분